KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angi (ANGI) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Angi (ANGI) over the last 9 years, with Q3 2025 value amounting to $136000.0.

  • Angi's Gains from Investment Securities fell 8503.85% to $136000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 2864.84%. This contributed to the annual value of $7.6 million for FY2024, which is 2642.64% up from last year.
  • According to the latest figures from Q3 2025, Angi's Gains from Investment Securities is $136000.0, which was down 8503.85% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Angi's Gains from Investment Securities ranged from a high of $48.2 million in Q1 2021 and a low of $136000.0 during Q3 2025
  • Moreover, its 5-year median value for Gains from Investment Securities was $2.1 million (2022), whereas its average is $4.8 million.
  • Per our database at Business Quant, Angi's Gains from Investment Securities skyrocketed by 139497.21% in 2021 and then tumbled by 9725.54% in 2022.
  • Quarter analysis of 5 years shows Angi's Gains from Investment Securities stood at $5.8 million in 2021, then plummeted by 43.88% to $3.2 million in 2022, then tumbled by 62.53% to $1.2 million in 2023, then surged by 58.65% to $1.9 million in 2024, then plummeted by 92.94% to $136000.0 in 2025.
  • Its last three reported values are $136000.0 in Q3 2025, $2.2 million for Q2 2025, and $4.5 million during Q1 2025.